期刊:Nano LIFE [World Scientific] 日期:2024-11-09卷期号:16 (01)
标识
DOI:10.1142/s1793984424300127
摘要
Engineered nanomaterials, such as nanoparticles, nanocomposites and chalcogenides, possess distinct characteristics as a result of their extremely small size, leading to significant advancements in industries such as healthcare, electronics and energy. Nanomaterials play a crucial role in cancer immunotherapy by greatly improving the effectiveness of several treatments, including immune checkpoint inhibitors, T cell transfer therapy, monoclonal antibodies and therapeutic vaccines. They achieve this by enhancing drug transport and increasing targeting accuracy. Although they have the ability to bring about significant changes, obstacles, such as potential toxicity, environmental effect and manufacturing complexity, impede their widespread use. In order to address these problems, it is crucial to use tactics such as thorough biocompatibility testing, environmentally friendly production procedures and modern manufacturing technology. This study examines the progress and difficulties in using synthetic nanomaterials for cancer immunotherapy and suggests ways to ensure their safe and efficient incorporation into medical treatments.